PIOGLITAZONE

Brand name:

• Actos®

Form and strength:

Please search for and view the medicine's Public Summary Document (PSD) for more information

Submission sponsor:

CELLTRION HEALTHCARE AUSTRALIA PTY LTD

Condition/indication:
(therapeutic use)

• Type 2 diabetes mellitus

Listing requested:

Please see PSD for more information

Funding program:

Please see PSD for more information

Request authority level:

Please see PSD for more information

PBAC Submission type:

New listing (Category 2)

Comment:

--

Other PBAC consideration:

--

Submission received for:

May 2025 PBAC meeting

Opportunity for consumer comment:

Open 02/04/2025 and close 02/05/2025 (see PBS Website)

PBAC meeting:

Held on 09/05/2025

PBAC outcome published:

Recommended (see PBAC Outcomes)

Notice of intent submitted:

27/06/2025

Lodgement of required documentation:

14/07/2025

Acceptance of complete documentation:

Accepted

Agreement to listing arrangements:

Commenced on 24/07/2025

Status:

Finalised

Government processes:

Commenced on 24/07/2025

Medicine listed on the PBS:

01/03/2026 (see PBS schedule)